The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia

American Journal of Rhinology and Allergy

Volumn 26, Issue 5, 2012, Pages 401-402

  Richer, Sara L ^a   Geisthoff, Urban W ^b   Livada, Nancy ^a   Ward, P Daniel ^c   Johnson, Leland ^c   Mainka, Alexander ^d   Henderson, Katharine J ^e   Maune, Steffen ^b   White, Robert I ^e   Ross, Douglas A ^a  

^a ST VINCENT S MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ANOSMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE SEVERITY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; MALE; OTORHINOLARYNGOLOGY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; RENDU OSLER WEBER DISEASE; REPEAT PROCEDURE; SURGICAL TECHNIQUE; WOUND DEHISCENCE; XEROSTOMIA; YOUNG PROCEDURE;

EID: 84866333870     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3809     Document Type: Article

References (18)

1. Saunders WH. Permanent control of nosebleeds in patients with hereditary hemorrhagic telangiectasia. Ann Intern med 53:147-152, 1960.
2. Young A. Closure of the nostrils in atrophic rhinitis. J Laryngol Otol 81:515-524, 1967.
3. Brooker DS, and Cinnamond MJ. Young's procedure in the treatment of epistaxis. J Laryngol Otol 105:847-848, 1991.
4. Hosni AA, and Innes AJ. Hereditary haemorrhagic telangiectasia: Young's procedure in the management of epistaxis. J Laryngol Otol 108:754-757, 1994. (Pubitemid 24291192)
5. Gluckman JL, and Portugal LG. Modified young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104:1174-1177, 1994. (Pubitemid 24284730)
6. Lund VJ, and Howard DJ. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngol Otol 111:30-33, 1997. (Pubitemid 27089218)
7. Robinson K, Gatehouse S, and Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 105:415-422, 1996. (Pubitemid 26177091)
8. Dheyauldeen S, Abdelnoor M, and Bachmann-Harildstad G. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: A cross-sectional study. Am J Rhinol Allergy 25:214-218, 2011.
9. Jorgensen G, Lange B, Wanscher JH, et al. Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia. Eur Arch Otorhinolaryngol 268:1765-1770, 2011.
10. Karapantzos I, Tsimpiris N, Goulis DG, et al. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:Yag laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262:830-833, 2005. (Pubitemid 41605797)
11. Harvey RJ, Kanagalingam J, and Lund VJ. The impact of septodermoplasty and posassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis. Am J Rhinol 22:182-187, 2008. (Pubitemid 351570562)
12. Ghaheri BA, Fong KJ, and Hwang PH. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 134:1006-1009, 2006. (Pubitemid 43766557)
13. Trojanowski P, Jargiello T, Trojanowska A, et al. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization. Acta Radiol 52:846-849, 2011.
14. Karnezis TT, and Davidson TM. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy. Laryngoscope 122:495-497, 2012.
15. Fiorella ML, Ross DA, Henderson KJ, et al. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115:301-305, 2005. (Pubitemid 40216708)
16. Levine CG, Ross DA, Henderson KJ, et al. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 138:721-724, 2008. (Pubitemid 351707539)
17. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet 48:73-87, 2011.
18. Hitchings AE, Lennox PA, Lund VJ, et al. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:75-78, 2005. (Pubitemid 40444009)